Caretrust Financials

CTRE

Source SEC Filings (10-K/10-Q) Updated Feb 12, 2026 Currency USD FYE February

This page shows Caretrust (CTRE) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 14 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Financial Health Signals

Piotroski F-Score Neutral

6/9

Caretrust passes 6 of 9 financial strength tests. All 4 profitability signals pass (positive income, cash flow, and earnings quality), 1 of 2 leverage/liquidity signals pass, both operating efficiency signals pass.

Earnings Quality Cash-Backed

1.23x

For every $1 of reported earnings, Caretrust generates $1.23 in operating cash flow ($394K OCF vs $321K net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Key Financial Metrics

Export CSV

Revenue

$476K

YoY-99.8%

5Y CAGR-69.4%

10Y CAGR-39.7%

Caretrust generated $476K in revenue in fiscal year 2025. This represents a decrease of 99.8% from the prior year.

EBITDA

N/A

Free Cash Flow

N/A

Net Income

$321K

YoY-99.7%

5Y CAGR-66.9%

10Y CAGR-29.1%

Caretrust reported $321K in net income in fiscal year 2025. This represents a decrease of 99.7% from the prior year.

EPS (Diluted)

$1.57

YoY+96.3%

5Y CAGR+13.1%

10Y CAGR+19.7%

Caretrust earned $1.57 per diluted share (EPS) in fiscal year 2025. This represents an increase of 96.3% from the prior year.

Cash & Debt

$198K

YoY-99.9%

5Y CAGR-59.8%

10Y CAGR-33.4%

Caretrust held $198K in cash against $398K in long-term debt as of fiscal year 2025.

Dividends Per Share

$1.12

YoY-3.4%

5Y CAGR+2.3%

10Y CAGR+5.8%

Caretrust paid $1.12 per share in dividends in fiscal year 2025. This represents a decrease of 3.4% from the prior year.

Shares Outstanding

223M

YoY+19.0%

5Y CAGR+18.4%

10Y CAGR+16.6%

Caretrust had 223M shares outstanding in fiscal year 2025. This represents an increase of 19.0% from the prior year.

Gross Margin

N/A

Operating Margin

N/A

Net Margin

67.3%

YoY+25.1pp

5Y CAGR+21.9pp

10Y CAGR+53.9pp

Caretrust's net profit margin was 67.3% in fiscal year 2025, showing the share of revenue converted to profit. This is up 25.1 percentage points from the prior year.

Return on Equity

7.9%

YoY+3.6pp

5Y CAGR-0.9pp

10Y CAGR+4.1pp

Caretrust's ROE was 7.9% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is up 3.6 percentage points from the prior year.

R&D Spending

N/A

Share Buybacks

N/A

Capital Expenditures

N/A

CTRE Income Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Revenue	$476K-99.8%	$296.3M+36.1%	$217.8M+11.0%	$196.1M+2.0%	$192.4M+7.9%	$178.3M
Cost of Revenue	N/A	N/A	N/A	N/A	$0-100.0%	$1.9M
Gross Profit	N/A	N/A	N/A	N/A	$192.4M+9.0%	$176.5M
R&D Expenses	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	$52K-99.8%	$28.9M+32.6%	$21.8M+8.1%	$20.2M-25.0%	$26.9M+64.9%	$16.3M
Operating Income	N/A	N/A	N/A	N/A	N/A	N/A
Interest Expense	$44K-99.9%	$30.3M-25.9%	$40.9M+36.2%	$30.0M+26.7%	$23.7M+0.1%	$23.7M
Income Tax	$5K	$0	$0	N/A	N/A	N/A
Net Income	$321K-99.7%	$125.1M+132.8%	$53.7M+815.9%	-$7.5M-110.4%	$72.0M-11.0%	$80.9M
EPS (Diluted)	$1.57+96.3%	$0.80+60.0%	$0.50+725.0%	$-0.08-110.8%	$0.74-12.9%	$0.85

Metric	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24
Revenue	$134.9M+1.8%	$132.4M+17.8%	$112.5M+16.4%	$96.6M+11.1%	$86.9M+12.4%	$77.4M+12.3%	$68.9M+9.2%	$63.1M
Cost of Revenue	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Gross Profit	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
R&D Expenses	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	$15.5M+0.3%	$15.4M+22.9%	$12.5M+39.1%	$9.0M-2.8%	$9.3M+39.4%	$6.7M+8.6%	$6.1M-10.3%	$6.8M
Operating Income	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Interest Expense	$11.4M-9.9%	$12.6M-3.2%	$13.0M+95.5%	$6.7M+30.2%	$5.1M-38.1%	$8.3M-4.6%	$8.7M+5.5%	$8.2M
Income Tax	N/A	$2.1M+101.7%	$1.0M	N/A	N/A	$0	$0	N/A
Net Income	$111.3M+48.6%	$74.9M+9.3%	$68.5M+4.2%	$65.8M+26.2%	$52.1M+55.9%	$33.4M+210.8%	$10.8M-62.6%	$28.7M
EPS (Diluted)	$0.52+48.6%	$0.350.0%	$0.350.0%	$0.35+16.7%	$0.30+42.9%	$0.21+200.0%	$0.07-68.2%	$0.22

CTRE Balance Sheet

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Total Assets	$5.1M-99.9%	$3.4B+64.9%	$2.1B+28.6%	$1.6B-1.2%	$1.6B+9.1%	$1.5B
Current Assets	N/A	N/A	N/A	N/A	N/A	N/A
Cash & Equivalents	$198K-99.9%	$213.8M-27.4%	$294.4M+2134.4%	$13.2M-33.8%	$19.9M+5.2%	$18.9M
Inventory	N/A	N/A	N/A	N/A	N/A	N/A
Accounts Receivable	$10K-99.1%	$1.2M+197.2%	$395K-5.0%	$416K-82.8%	$2.4M+32.6%	$1.8M
Goodwill	N/A	N/A	N/A	N/A	N/A	N/A
Total Liabilities	$1.1M-99.8%	$507.6M-23.8%	$666.1M-13.6%	$771.4M+6.4%	$725.1M+23.0%	$589.4M
Current Liabilities	N/A	N/A	N/A	N/A	N/A	N/A
Long-Term Debt	$398K-99.9%	$396.9M-33.4%	$595.6M-17.2%	$719.5M+6.8%	$673.4M+23.4%	$545.6M
Total Equity	$4.0M-99.9%	$2.9B+105.3%	$1.4B+66.8%	$849.4M-7.2%	$915.8M+0.2%	$914.1M
Retained Earnings	N/A	N/A	N/A	N/A	N/A	N/A

Metric	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24
Total Assets	$5.1B+1.2%	$5.1B+9.3%	$4.7B+19.9%	$3.9B+13.0%	$3.4B+17.7%	$2.9B+8.2%	$2.7B+14.9%	$2.3B
Current Assets	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Cash & Equivalents	$198.0M-72.2%	$712.5M+132.8%	$306.1M+1054.5%	$26.5M-87.6%	$213.8M-43.3%	$377.1M-23.8%	$495.1M+9.7%	$451.2M
Inventory	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Accounts Receivable	$10.4M+40.3%	$7.4M+175.0%	$2.7M+37.5%	$2.0M+66.4%	$1.2M+33.3%	$881K-19.6%	$1.1M+172.6%	$402K
Goodwill	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Total Liabilities	$1.1B+1.7%	$1.1B-19.5%	$1.3B+42.2%	$936.3M+84.4%	$507.6M+2.3%	$496.1M-34.1%	$753.0M+12.0%	$672.3M
Current Liabilities	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Long-Term Debt	$894.2M0.0%	$893.8M-22.6%	$1.2B+40.5%	$822.1M+107.1%	$396.9M+0.1%	$396.7M-40.9%	$671.1M+12.6%	$595.9M
Total Equity	$4.0B+1.0%	$4.0B+21.0%	$3.3B+12.7%	$2.9B+0.6%	$2.9B+20.1%	$2.4B+24.6%	$1.9B+16.1%	$1.7B
Retained Earnings	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

CTRE Cash Flow Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Operating Cash Flow	$394K-99.8%	$244.3M+57.8%	$154.8M+7.2%	$144.4M-7.9%	$156.9M+7.6%	$145.7M
Capital Expenditures	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow	N/A	N/A	N/A	N/A	N/A	N/A
Investing Cash Flow	$1.5M+100.1%	-$1.5B-465.2%	-$267.8M-110.2%	-$127.4M+33.9%	-$192.6M-363.3%	-$41.6M
Financing Cash Flow	$1.1M-99.9%	$1.2B+201.5%	$394.3M+1761.5%	-$23.7M-164.6%	$36.7M+134.8%	-$105.6M
Dividends Paid	$259K-99.8%	$172.2M+49.1%	$115.5M+8.8%	$106.1M+5.3%	$100.8M+8.2%	$93.2M
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A

Metric	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24
Operating Cash Flow	$121.0M+19.9%	$100.9M+0.1%	$100.8M+41.2%	$71.4M-5.1%	$75.2M+11.8%	$67.2M+26.9%	$53.0M+8.5%	$48.8M
Capital Expenditures	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Investing Cash Flow	-$560.3M-639.7%	-$75.7M+90.4%	-$789.4M-2098.3%	-$35.9M+94.8%	-$685.6M-90.7%	-$359.4M-4.1%	-$345.4M-180.3%	-$123.2M
Financing Cash Flow	-$75.3M-119.7%	$381.2M+5.4%	$361.8M-5.6%	$383.2M-14.3%	$447.1M+156.7%	$174.2M-48.2%	$336.4M+45.5%	$231.1M
Dividends Paid	$74.8M+11.5%	$67.1M+6.4%	$63.1M+15.9%	$54.4M+9.4%	$49.7M+11.2%	$44.7M+8.6%	$41.2M+12.8%	$36.5M
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

CTRE Financial Ratios

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Gross Margin	N/A	N/A	N/A	N/A	100.0%+1.0pp	99.0%
Operating Margin	N/A	N/A	N/A	N/A	N/A	N/A
Net Margin	67.3%+25.1pp	42.2%+17.5pp	24.7%+28.5pp	-3.8%-41.3pp	37.4%-7.9pp	45.4%
Return on Equity	7.9%+3.6pp	4.3%+0.5pp	3.8%	N/A	7.9%-1.0pp	8.8%
Return on Assets	6.2%+2.6pp	3.6%+1.1pp	2.6%+3.0pp	-0.5%-4.9pp	4.4%-1.0pp	5.4%
Current Ratio	N/A	N/A	N/A	N/A	N/A	N/A
Debt-to-Equity	0.10-0.0	0.14-0.3	0.42-0.4	0.85+0.1	0.74+0.1	0.60
FCF Margin	N/A	N/A	N/A	N/A	N/A	N/A

Metric	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24
Gross Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Net Margin	82.5%+26.0pp	56.5%-4.4pp	61.0%-7.2pp	68.1%+8.1pp	60.0%+16.7pp	43.2%+27.6pp	15.6%-30.0pp	45.6%
Return on Equity	2.8%+0.9pp	1.9%-0.2pp	2.1%-0.2pp	2.3%+0.5pp	1.8%+0.4pp	1.4%+0.8pp	0.5%-1.2pp	1.7%
Return on Assets	2.2%+0.7pp	1.5%0.0pp	1.5%-0.2pp	1.7%+0.2pp	1.5%+0.4pp	1.1%+0.7pp	0.4%-0.8pp	1.2%
Current Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Debt-to-Equity	0.220.0	0.22-0.1	0.35+0.1	0.28+0.1	0.14-0.0	0.16-0.2	0.35-0.0	0.36
FCF Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Similar Companies

AMERICAN HEALTHCARE REIT INC AHR

$9.2B

Healthcare Tr Amer Inc HR

$6.3B

Sabra Health Care Reit Inc SBRA

$5.1B

Medical Prop MPW

$3.0B

National Health Investors NHI

$4.3B

Frequently Asked Questions

What is Caretrust's annual revenue?

Caretrust (CTRE) reported $476K in total revenue for fiscal year 2025. This represents a -99.8% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Caretrust's revenue growing?

Caretrust (CTRE) revenue declined by 99.8% year-over-year, from $296.3M to $476K in fiscal year 2025.

Is Caretrust profitable?

Yes, Caretrust (CTRE) reported a net income of $321K in fiscal year 2025, with a net profit margin of 67.3%.

What is Caretrust's earnings per share (EPS)?

Caretrust (CTRE) reported diluted earnings per share of $1.57 for fiscal year 2025. This represents a 96.3% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

How much debt does Caretrust have?

As of fiscal year 2025, Caretrust (CTRE) had $198K in cash and equivalents against $398K in long-term debt.

What is Caretrust's net profit margin?

Caretrust (CTRE) had a net profit margin of 67.3% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Does Caretrust pay dividends?

Yes, Caretrust (CTRE) paid $1.12 per share in dividends during fiscal year 2025.

What is Caretrust's return on equity (ROE)?

Caretrust (CTRE) has a return on equity of 7.9% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is Caretrust's operating cash flow?

Caretrust (CTRE) generated $394K in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are Caretrust's total assets?

Caretrust (CTRE) had $5.1M in total assets as of fiscal year 2025, including both current and long-term assets.

How many shares does Caretrust have outstanding?

Caretrust (CTRE) had 223M shares outstanding as of fiscal year 2025.

What is Caretrust's debt-to-equity ratio?

Caretrust (CTRE) had a debt-to-equity ratio of 0.10 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Caretrust's return on assets (ROA)?

Caretrust (CTRE) had a return on assets of 6.2% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is Caretrust's Piotroski F-Score?

Caretrust (CTRE) has a Piotroski F-Score of 6 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7–9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Caretrust's earnings high quality?

Caretrust (CTRE) has an earnings quality ratio of 1.23x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.